Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The global pipeline of cell therapies for cancer

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 18, 821-822 (2019)


Updates & Corrections

  • Clarification 09 September 2019: In addition to the trials of agents included in Figure 1, there is an ongoing phase III trial of tumour-infiltrating lymphocytes in patients with melanoma sponsored by The Netherlands Cancer Institute (NCT02278887), which is included in Supplementary Figure 4.

Supplementary Information

  1. Supplementary information

Competing Interests

The authors declare no competing interests.

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links